FABP4 and metabolic dysfunction-associated steatotic liver disease: Previous studies have reported increased FABP4 mRNA expression and FABP4 protein in the culture medium using in vitro models of EtOH- and fat-induced cell steatosis, and in animal models of ALD and NAFLD, increased hepatic FABP4 mRNA and serum FABP4.